Proline-rich sequence recognition domains (PRD): Ligands, function and inhibition

Handbook of Experimental Pharmacology

Volumn 186, Issue , 2008, Pages 407-429

  Freund, C ^a   Schmalz, H G ^b   Sticht, J ^a   Kuhne R ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PROLINE;

ANIMAL; BINDING SITE; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; ANIMALS; BINDING SITES; DRUG DELIVERY SYSTEMS; HUMANS; LIGANDS; PROLINE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 49049108952     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-72843-6_17     Document Type: Article

References (149)

1. Adzhubei AA, Sternberg MJ (1993) Left-handed polyproline II helices commonly occur in globular proteins. J Mol Biol 229:472-493
2. Al Dhaheri MH, Shah YM, Basrur V, Pind S, Rowan BG (2006) Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells. Steroids 71:966-978
3. Aqeilan RI, Donati V, Palamarchuk A, Trapasso F, Kaou M, Pekarsky Y, Sudol M, Croce CM (2005) WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res 65:6764-6772
4. Arkin MR, Wells JA (2004) Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 3:301-317
5. Arkin MR, Randal M, DeLano WL, Hyde J, Luong TN, Oslob JD, Raphael DR, Taylor L, Wang J, McDowell RS, Wells JA, Braisted AC (2003) Binding of small molecules to an adaptive protein-protein interface. Proc Natl Acad Sci USA 100:1603-1608
6. Babst M (2005) A protein's final ESCRT. Traffic 6:2-9
7. Ball LJ, Kuhne R, Schneider-Mergener J, Oschkinat H (2005) Recognition of proline-rich motifs by protein-protein-interaction domains. Angew Chem Int Ed Engl 44:2852-2869
8. Bandur NG, Harms K, Koert U (2005) First stereoselective synthesis of a pro-pro E-alkene dipeptide isostere. Synlett 773-776
9. Bear JE, Svitkina TM, Krause M, Schafer DA, Loureiro JJ, Strasser GA, Maly IV, Chaga OY, Cooper JA, Borisy GG, Gertler FB (2002) Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell 109:509-521
10. Bedford MT, Chan DC, Leder P (1997) FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. EMBO J 16:2376-2383
11. Bedford MT, Frankel A, Yaffe MB, Clarke S, Leder P, Richard S (2000) Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J Biol Chem 275:16030-16036
12. Ben Yosef R, Starr A, Karaush V, Loew V, Lev-Ari S, Barnea I, Lidawi G, Shtabsky A, Greif Y, Yarden Y, Vexler A (2007) ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy. Prostate 67:871-880
13. Bhaskar K, Yen SH, Lee G (2005) Disease-related modifications in tau affect the interaction between Fyn and Tau. J Biol Chem 280:35119-35125
14. Bieniasz PD (2006) Late budding domains and host proteins in enveloped virus release. Virology 344:55-63
15. Bleicher KH, Bohm HJ, Muller K, Alanine AI (2003) Hit and lead generation: beyond highthroughput screening. Nat Rev Drug Discov 2:369-378
16. Bochicchio B, Tamburro AM (2002) Polyproline II structure in proteins: identification by chiroptical spectroscopies, stability, and functions. Chirality 14:782-792
17. Boggon TJ, Eck MJ (2004) Structure and regulation of Src family kinases. Oncogene 23:7918-7927
18. Bork P, Sudol M (1994) The WW domain: a signalling site in dystrophin? Trends Biochem Sci 19:531-533
19. Carlsson L, Nystrom LE, Sundkvist I, Markey F, Lindberg U (1977) Actin polymerizability is influenced by profilin, a low molecular weight protein in non-muscle cells. J Mol Biol 115:465-483
20. Carstens MJ, Krempler A, Triplett AA, Van Lohuizen M, Wagner KU (2004) Cell cycle arrest and cell death are controlled by p53-dependent and p53-independent mechanisms in Tsg101-deficient cells. J Biol Chem 279:35984-35994
21. Cesareni G, Panni S, Nardelli G, Castagnoli L (2002) Can we infer peptide recognition specificity mediated by SH3 domains? FEBS Lett 513:38-44
22. Chakraborty T, Ebel F, Domann E, Niebuhr K, Gerstel B, Pistor S, Temm-Grove CJ, Jockusch BM, Reinhard M, Walter U (1995) A focal adhesion factor directly linking intracellularly motile Listeria monocytogenes and Listeria ivanovii to the actin-based cytoskeleton of mammalian cells. EMBO J 14:1314-1321
23. Chan B, Lanyi A, Song HK, Griesbach J, Simarro-Grande M, Poy F, Howie D, Sumegi J, Terhorst C, Eck MJ (2003) SAP couples Fyn to SLAM immune receptors. Nat Cell Biol 5:155-160
24. Chin J, Palop JJ, Puolivali J, Massaro C, Bien-Ly N, Gerstein H, Scearce-Levie K, Masliah E, Mucke L (2005) Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J Neurosci 25:9694-9703
25. Clackson T, Wells JA (1995) A hot spot of binding energy in a hormone-receptor interface. Science 267:383-386
26. Cubellis MV, Caillez F, Blundell TL, Lovell SC (2005) Properties of polyproline II, a secondary structure element implicated in protein-protein interactions. Proteins 58:880-892
27. de Bakker PI, Bateman A, Burke DF, Miguel RN, Mizuguchi K, Shi J, Shirai H, Blundell TL (2001) HOMSTRAD: adding sequence information to structure-based alignments of homologous protein families. Bioinformatics 17:748-749
28. Demirov DG, Ono A, Orenstein JM, Freed EO (2002) Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci USA 99:955-960
29. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ (2000) Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain Cell 103:351-361
30. Derry JM, Ochs HD, Francke U (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 79:635-644
31. Derry JM, Kerns JA, Weinberg KI, Ochs HD, Volpini V, Estivill X, Walker AP, Francke U (1995) WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Hum Mol Genet 4:1127-1135
32. Dev KK (2004) Making protein interactions druggable: targeting PDZ domains. Nat Rev Drug Discov 3:1047-1056
33. Doi M, Nishi Y, Uchiyama S, Nishiuchi Y, Nishio H, Nakazawa T, Ohkubo T, Kobayashi Y (2005) Collagen-like triple helix formation of synthetic (Pro-Pro-Gly)10 analogues: (4(S)-hydroxyprolyl-4(R)-hydroxyprolyl-Gly)10, (4(R)-hydroxyprolyl-4(R)-hydroxyprolyl-Gly)10 and (4(S)-fluoroprolyl-4(R)-fluoroprolyl-Gly)10. J Pept Sci 11:609-616
34. Dustin ML, Olszowy MW, Holdorf AD, Li J, Bromley S, Desai N, Widder P, Rosenberger F, van der Merwe PA, Allen PM, Shaw AS (1998) A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 94:667-677
35. Fischer PM, Lane DP (2004) Small-molecule inhibitors of the p53 suppressor HDM2: have protein-protein interactions come of age as drug targets? Trends Pharmacol Sci 25:343-346
36. Frank R (2002) The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J Immunol Methods 267:13-26
37. Freund C, Dotsch V, Nishizawa K, Reinherz EL, Wagner G (1999) The GYF domain is a novel structural fold that is involved in lymphoid signaling through proline-rich sequences. Nat Struct Biol 6:656-660
38. Freund C, Kuhne R, Yang H, Park S, Reinherz EL, Wagner G (2002) Dynamic interaction of CD2 with the GYF and the SH3 domain of compartmentalized effector molecules. EMBO J 21:5985-5995
39. Fukai I, Hussey RE, Sunder-Plassmann R, Reinherz EL (2000) A critical role for p59(fyn) in CD2-based signal transduction. Eur J Immunol 30:3507-3515
40. Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, Wettstein DA, Stray KM, Cote M, Rich RL, Myszka DG, Sundquist WI (2001) Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55-65
41. Goila-Gaur R, Demirov DG, Orenstein JM, Ono A, Freed EO (2003) Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression. J Virol 77:6507-6519
42. Goldstrohm AC, Albrecht TR, Sune C, Bedford MT, Garcia-Blanco MA (2001) The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol Cell Biol 21:7617-7628
43. Golemi-Kotra D, Mahaffy R, Footer MJ, Holtzman JH, Pollard TD, Theriot JA, Schepartz A (2004) High affinity, paralog-specific recognition of the Mena EVH1 domain by a miniature protein. J Am Chem Soc 126:4-5
44. Gorina S, Pavletich NP (1996) Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274:1001-1005
45. Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA (1991) Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci USA 88:3195-3199
46. Groemping Y, Lapouge K, Smerdon SJ, Rittinger K (2003) Molecular basis of phosphorylationinduced activation of the NADPH oxidase. Cell 113:343-355
47. Harkiolaki M, Lewitzky M, Gilbert RJ, Jones EY, Bourette RP, Mouchiroud G, Sondermann H, Moarefi I, Feller SM (2003) Structural basis for SH3 domain-mediated high-affinity binding between Mona/Gads and SLP-76. EMBO J 22:2571-2582
48. Harris BZ, Lim WA (2001) Mechanism and role of PDZ domains in signaling complex assembly. J Cell Sci 114:3219-3231
49. He MM, Smith AS, Oslob JD, Flanagan WM, Braisted AC, Whitty A, Cancilla MT, Wang J, Lugovskoy AA, Yoburn JC, Fung AD, Farrington G, Eldredge JK, Day ES, Cruz LA, Cachero TG, Miller SK, Friedman JE, Choong IC, Cunningham BC (2005) Small-molecule inhibition of TNF-alpha. Science 310:1022-1025
50. Hofmann RM, Pickart CM (1999) Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell 96:645-653
51. Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C, Hayden MR, Margolis RL, Ross CA, Dausset J, Ferrante RJ, Neri C (2001) The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci USA 98:1811-1816
52. Holmgren SK, Bretscher LE, Taylor KM, Raines RT (1999) A hyperstable collagen mimic. Chem Biol 6:63-70
53. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A, Morris JC, Wilhelmsen KC, Schellenberg GD, Trojanowski JQ, Lee VM (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282:1914-1917
54. Huang M, Orenstein JM, Martin MA, Freed EO (1995) p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol 69:6810-6818
55. Hurley JH, Emr SD (2006) The ESCRT complexes: structure and mechanism of a membrane-trafficking network. Annu Rev Biophys Biomol Struct 35:277-298
56. Ilsley JL, Sudol M, Winder SJ (2002) The WW domain: linking cell signalling to the membrane cytoskeleton. Cell Signal 14:183-189
57. Ingham RJ, Gish G, Pawson T (2004) The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture. Oncogene 23:1972-1984
58. Inglis SR, Stojkoski C, Branson KM, Cawthray JF, Fritz D, Wiadrowski E, Pyke SM, Booker GW (2004) Identification and specificity studies of small-molecule ligands for SH3 protein domains. J Med Chem 47:5405-5417
59. Inglis SR, Jones RK, Booker GW, Pyke SM (2006) Synthesis of N-benzylated-2-aminoquinolines as ligands for the Tec SH3 domain. Bioorg Med Chem Lett 16:387-390
60. Junttila TT, Sundvall M, Lundin M, Lundin J, Tanner M, Harkonen P, Joensuu H, Isola J, Elenius K (2005) Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Res 65:1384-1393
61. Kanelis V, Rotin D, Forman-Kay JD (2001) Solution structure of a Nedd4 WW domain-ENaC peptide complex. Nat Struct Biol 8:407-412
62. Karkkainen S, Hiipakka M, Wang JH, Kleino I, Vaha-Jaakkola M, Renkema GH, Liss M, Wagner R, Saksela K (2006) Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome. EMBO Rep 7:186-191
63. Kaushik N, Fear D, Richards SC, McDermott CR, Nuwaysir EF, Kellam P, Harrison TJ, Wilkinson RJ, Tyrrell DA, Holgate ST, Kerr JR (2005) Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol 58:826-832
64. Kay BK, Williamson MP, Sudol M (2000) The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 14:231-241
65. Kentsis A, Mezei M, Gindin T, Osman R (2004) Unfolded state of polyalanine is a segmented polyproline II helix. Proteins 55:493-501
66. Kim HH, Tharayil M, Rudd CE (1998) Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. J Biol Chem 273:296-301
67. Kofler MM, Freund C (2006) The GYF domain. FEBS J 273:245-256
68. Kofler M, Heuer K, Zech T, Freund C (2004) Recognition sequences for the GYF domain reveal a possible spliceosomal function of CD2BP2. J Biol Chem 279:28292-28297
69. Kofler M, Motzny K, Freund C (2005) GYF Domain proteomics reveals interaction sites in known and novel target proteins. Mol Cell Proteomics 4:1797-1811
70. Kolluri R, Shehabeldin A, Peacocke M, Lamhonwah AM, Teichert-Kuliszewska K, Weissman SM, Siminovitch KA (1995) Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus. Hum Mol Genet 4:1119-1126
71. Komuro A, Nagai M, Navin NE, Sudol M (2003) WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 278:33334-33341
72. Krempler A, Henry MD, Triplett AA, Wagner KU (2002) Targeted deletion of the Tsg101 gene results in cell cycle arrest at G1/S and p53-independent cell death. J Biol Chem 277:43216-43223
73. Laggerbauer B, Liu S, Makarov E, Vornlocher HP, Makarova O, Ingelfinger D, Achsel T, Luhrmann R (2005) The human U5 snRNP 52 K protein (CD2BP2) interacts with U5-102 K (hPrp6), a U4/U6.U5 tri-snRNP bridging protein, but dissociates upon tri-snRNP formation. RNA 11:598-608
74. Laurent V, Loisel TP, Harbeck B, Wehman A, Grobe L, Jockusch BM, Wehland J, Gertler FB, Carlier MF (1999) Role of proteins of the Ena/VASP family in actin-based motility of Listeria monocytogenes. J Cell Biol 144:1245-1258
75. Lawrence DS (2005) Signaling protein inhibitors via the combinatorial modification of peptide scaffolds. Biochim Biophys Acta 1754:50-57
76. Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G (1998) Tau interacts with src-family non-receptor tyrosine kinases. J Cell Sci 111( Pt 21):3167-3177
77. Li SS (2005) Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J 390:641-653
78. Li H, Lawrence DS (2005) Acquisition of Fyn-selective SH3 domain ligands via a combinatorial library strategy. Chem Biol 12:905-912
79. Lim WA (1996) Reading between the lines: SH3 recognition of an intact protein. Structure 4:657-659
80. Lin H, Hutchcroft JE, Andoniou CE, Kamoun M, Band H, Bierer BE (1998) Association of p59(fyn) with the T lymphocyte costimulatory receptor CD2. Binding of the Fyn Src homology (SH) 3 domain is regulated by the Fyn SH2 domain. J Biol Chem 273:19914-19921
81. Liu Q, Berry D, Nash P, Pawson T, McGlade CJ, Li SS (2003) Structural basis for specific binding of the Gads SH3 domain to an RxxK motif-containing SLP-76 peptide: a novel mode of peptide recognition. Mol Cell 11:471-481
82. Liu F, Stephen AG, Adamson CS, Gousset K, Aman MJ, Freed EO, Fisher RJ, Burke TR, Jr. (2006) Hydrazone-and hydrazide-containing N-substituted glycines as peptoid surrogates for expedited library synthesis: application to the preparation of Tsg101-directed HIV-1 budding antagonists. Org Lett 8:5165-5168
83. Lu PJ, Zhou XZ, Shen M, Lu KP (1999) Function of WW domains as phosphoserine-or phosphothreonine-binding modules. Science 283:1325-1328
84. Lubs H, Abidi FE, Echeverri R, Holloway L, Meindl A, Stevenson RE, Schwartz CE (2006) Golabi-Ito-Hall syndrome results from a missense mutation in the WW domain of the PQBP1 gene. J Med Genet 43:e30
85. Macias MJ, Hyvonen M, Baraldi E, Schultz J, Sudol M, Saraste M, Oschkinat H (1996) Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature 382:646-649
86. Mayer BJ (2001) SH3 domains: complexity in moderation. J Cell Sci 114:1253-1263
87. Mezei M, Fleming PJ, Srinivasan R, Rose GD (2004) Polyproline II helix is the preferred conformation for unfolded polyalanine in water. Proteins 55:502-507
88. Mizuguchi K, Deane CM, Blundell TL, Overington JP (1998) HOMSTRAD: a database of protein structure alignments for homologous families. Protein Sci 7:2469-2471
89. Montclare JK, Schepartz A (2003) Miniature homeodomains: high specificity without an N-terminal arm. J Am Chem Soc 125:3416-3417
90. Morita E, Sundquist WI (2004) Retrovirus budding. Annu Rev Cell Dev Biol 20:395-425
91. Musacchio A, Saraste M, Wilmanns M (1994a) High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nat Struct Biol 1:546-551
92. Musacchio A, Wilmanns M, Saraste M (1994b) Structure and function of the SH3 domain. Prog Biophys Mol Biol 61:283-297
93. Myllyharju J, Kivirikko KI (1999) Identification of a novel proline-rich peptide-binding domain in prolyl 4-hydroxylase. EMBO J 18:306-312
94. Nash P, Tang X, Orlicky S, Chen Q, Gertler FB, Mendenhall MD, Sicheri F, Pawson T, Tyers M (2001) Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414:514-521
95. Nguyen JT, Turck CW, Cohen FE, Zuckermann RN, Lim WA (1998) Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. Science 282:2088-2092
96. Nguyen JT, Porter M, Amoui M, Miller WT, Zuckermann RN, Lim WA (2000) Improving SH3 domain ligand selectivity using a non-natural scaffold. Chem Biol 7:463-473
97. Ni CY, Murphy MP, Golde TE, Carpenter G (2001) gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294:2179-2181
98. Niebuhr K, Ebel F, Frank R, Reinhard M, Domann E, Carl UD, Walter U, Gertler FB, Wehland J, Chakraborty T (1997) A novel proline-rich motif present in ActA of Listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family. EMBO J 16:5433-5444
99. Nielsen TK, Liu S, Luhrmann R, Ficner R (2007) Structural basis for the bifunctionality of the U5 snRNP 52 K protein (CD2BP2). J Mol Biol 369:902-908
100. Nishi Y, Uchiyama S, Doi M, Nishiuchi Y, Nakazawa T, Ohkubo T, Kobayashi Y (2005) Different effects of 4-hydroxyproline and 4-fluoroproline on the stability of collagen triple helix. Biochemistry 44:6034-6042
101. Nishizawa K, Freund C, Li J, Wagner G, Reinherz EL (1998) Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation. Proc Natl Acad Sci USA 95:14897-14902
102. Okkenhaug K, Rottapel R (1998) Grb2 forms an inducible protein complex with CD28 through a Src homology 3 domain-proline interaction. J Biol Chem 273:21194-21202
103. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O'Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW, Rosenberg SH (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435:677-681
104. Oneyama C, Nakano H, Sharma SV (2002) UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug. Oncogene 21:2037-2050
105. Oneyama C, Agatsuma T, Kanda Y, Nakano H, Sharma SV, Nakano S, Narazaki F, Tatsuta K (2003) Synthetic inhibitors of proline-rich ligand-mediated protein-protein interaction: potent analogs of UCS15A. Chem Biol 10:443-451
106. Orth JD, McNiven MA (2003) Dynamin at the actin-membrane interface. Curr Opin Cell Biol 15:31-39
107. Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, Scott D, Porteous DJ, Smyth JF, Gabra H, Watson JE (2001) WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci USA 98:11417-11422
108. Pornillos O, Alam SL, Davis DR, Sundquist WI (2002a) Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat Struct Biol 9:812-817
109. Pornillos O, Garrus JE, Sundquist WI (2002b) Mechanisms of enveloped RNA virus budding. Trends Cell Biol 12:569-579
110. Pornillos O, Higginson DS, Stray KM, Fisher RD, Garrus JE, Payne M, He GP, Wang HE, Morham SG, Sundquist WI (2003) HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. J Cell Biol 162:425-434
111. Prehoda KE, Lee DJ, Lim WA (1999) Structure of the enabled/VASP homology 1 domain-peptide complex: a key component in the spatial control of actin assembly. Cell 97:471-480
112. Qin ZH, Wang Y, Sapp E, Cuiffo B, Wanker E, Hayden MR, Kegel KB, Aronin N, DiFiglia M (2004) Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction. J Neurosci 24:269-281
113. Rothstein DM, Sayegh MH (2003) T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 196:85-108
114. Rutledge SE, Volkman HM, Schepartz A (2003) Molecular recognition of protein surfaces: high affinity ligands for the CBP KIX domain. J Am Chem Soc 125:14336-14347
115. Ruzza P, Siligardi G, Donella-Deana A, Calderan A, Hussain R, Rubini C, Cesaro L, Osler A, Guiotto A, Pinna LA, Borin G (2006) 4-Fluoroproline derivative peptides: effect on PPII conformation and SH3 affinity. J Pept Sci 12:462-471
116. Scaife RM, Margolis RL (1997) The role of the PH domain and SH3 binding domains in dynamin function. Cell Signal 9:395-401
117. Schild L, Lu Y, Gautschi I, Schneeberger E, Lifton RP, Rossier BC (1996) Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J 15:2381-2387
118. Sharma SV, Oneyama C, Yamashita Y, Nakano H, Sugawara K, Hamada M, Kosaka N, Tamaoki T (2001) UCS15A, a non-kinase inhibitor of Src signal transduction. Oncogene 20:2068-2079
119. Shiraishi-Yamaguchi Y, Furuichi T (2007) The Homer family proteins. Genome Biol 8:206
120. Southwick FS, Purich DL (1994) Arrest of Listeria movement in host cells by a bacterial ActA analogue: implications for actin-based motility. Proc Natl Acad Sci USA 91:5168-5172
121. Sreerama N, Woody RW (1999) Molecular dynamics simulations of polypeptide conformations in water: A comparison of alpha, beta, and poly(pro)II conformations. Proteins 36:400-406
122. Starr A, Greif J, Vexler A, Ashkenazy-Voghera M, Gladesh V, Rubin C, Kerber G, Marmor S, Lev-Ari S, Inbar M, Yarden Y, Ben Yosef R (2006) ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy. Int J Cancer 119:269-274
123. Staub O, Dho S, Henry P, Correa J, Ishikawa T, McGlade J, Rotin D (1996) WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome. EMBO J 15:2371-2380
124. Sudol M (1996) Structure and function of the WW domain. Prog Biophys Mol Biol 65:113-132
125. Sudol M, Sliwa K, Russo T (2001) Functions of WW domains in the nucleus. FEBS Lett 490:190-195
126. Szumlinski KK, Lominac KD, Oleson EB, Walker JK, Mason A, Dehoff MH, Klugmann M, Cagle S, Welt K, During M, Worley PF, Middaugh LD, Kalivas PW (2005) Homer2 is necessary for EtOH-induced neuroplasticity. J Neurosci 25:7054-7061
127. Szumlinski KK, Kalivas PW, Worley PF (2006) Homer proteins: implications for neuropsychiatric disorders. Curr Opin Neurobiol 16:251-257
128. Takeya R, Ueno N, Sumimoto H (2006) Regulation of superoxide-producing NADPH oxidases in nonphagocytic cells. Methods Enzymol, Regulators and Effectors of Small Gtpases: Rho Family 406:456-468
129. Tanaka M, Shibata H (1985) Poly(L-proline)-binding proteins from chick embryos are a profilin and a profilactin. Eur J Biochem 151:291-297
130. Tiffany ML, Krimm S (1968) Circular dichroism of poly-l-proline in an unordered conformation. Biopolymers 6:1767-1770
131. Tremmel P, Geyer A (2002) An oligomeric ser-pro dipeptide mimetic assuming the polyproline II helix conformation. J Am Chem Soc 124:8548-8549
132. VanDemark AP, Hofmann RM, Tsui C, Pickart CM, Wolberger C (2001) Molecular insights into polyubiquitin chain assembly: crystal structure of the Mms2/Ubc13 heterodimer. Cell 105:711-720
133. Varmus H, Hirai H, Morgan D, Kaplan J, Bishop JM (1989) Function, location, and regulation of the src protein-tyrosine kinase. Princess Takamatsu Symp 20:63-70
134. VerPlank L, Bouamr F, LaGrassa TJ, Agresta B, Kikonyogo A, Leis J, Carter CA (2001) Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci USA 98:7724-7729
135. Vetter SW, Zhang ZY (2002) Probing the phosphopeptide specificities of protein tyrosine phosphatases, SH2 and PTB domains with combinatorial library methods. Curr Protein Pept Sci 3:365-397
136. Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D, Strina D, Patrosso MC, Ramenghi U, Sacco MG, (1995) X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet 9:414-417
137. Volkman BF, Prehoda KE, Scott JA, Peterson FC, Lim WA (2002) Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich Syndrome. Cell 111:565-576
138. Wagner KU, Krempler A, Qi Y, Park K, Henry MD, Triplett AA, Riedlinger G, Rucker EB III, Hennighausen L (2003) Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues. Mol Cell Biol 23:150-162
139. Williams RL, Urbé S (2007) The emerging shape of the ESCRT machinery. Nat Rev Mol Cell Biol 8:355-368. Review.
140. Williams RS, Bernstein N, Lee MS, Rakovszky ML, Cui D, Green R, Weinfeld M, Glover JN (2005) Structural basis for phosphorylation-dependent signaling in the DNA-damage response. Biochem Cell Biol 83:721-727
141. Witter DJ, Famiglietti SJ, Cambier JC, Castelhano AL (1998) Design and synthesis of SH3 domain binding ligands: modifications of the consensus sequence XPpXP. Bioorg Med Chem Lett 8:3137-3142
142. Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P (1996) Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways. Transplantation 62:1011-1018
143. Xu W, Doshi A, Lei M, Eck MJ, Harrison SC (1999) Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell 3:629-638
144. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, Schreiber SL (1994) Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76:933-945
145. Zarrinpar A, Bhattacharyya RP, Lim WA (2003a) The structure and function of proline recognition domains. Sci STKE 2003:RE8
146. Zarrinpar A, Park SH, Lim WA (2003b) Optimization of specificity in a cellular protein interaction network by negative selection. Nature 426:676-680
147. Zhang Y, Lindblom T, Chang A, Sudol M, Sluder AE, Golemis EA (2000) Evidence that dim1 associates with proteins involved in pre-mRNA splicing, and delineation of residues essential for dim1 interactions with hnRNP F and Npw38/PQBP-1. Gene 257:33-43
148. Zhu Q, Watanabe C, Liu T, Hollenbaugh D, Blaese RM, Kanner SB, Aruffo A, Ochs HD (1997) Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood 90:2680-2689
149. Zimmermann J, Kuhne R, Volkmer-Engert R, Jarchau T, Walter U, Oschkinat H, Ball LJ (2003) Design of N-substituted peptomer ligands for EVH1 domains. J Biol Chem 278:36810-36818